Selective targeting of gene products with the megakaryocyte platelet factor 4 promoter. Ravid K, Beeler DL, Rabin MS, Ruley HE, Rosenberg RD (1991) Proc Natl Acad Sci U S A 88: 1521-5 Increased formation of thromboxane in vivo in humans with mastocytosis. Morrow JD, Oates JA, Roberts LJ, Zackert WE, Mitchell TA, Lazarus G, Guzzo C (1999) J Invest Dermatol 113: 93-7 A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical record. Karnes JH, Cronin RM, Rollin J, Teumer A, Pouplard C, Shaffer CM, Blanquicett C, Bowton EA, Cowan JD, Mosley JD, Van Driest SL, Weeke PE, Wells QS, Bakchoul T, Denny JC, Greinacher A, Gruel Y, Roden DM (2015) Thromb Haemost 113: 772-81 The multiple complexes formed by the interaction of platelet factor 4 with heparin. Bock PE, Luscombe M, Marshall SE, Pepper DS, Holbrook JJ (1980) Biochem J 191: 769-76 Reevaluation of the role of the polar groups of collagen in the platelet-collagen interaction. Chesney CM, Pifer DD, Crofford LJ, Huch KM (1983) Am J Pathol 112: 200-6
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.